aTyr Pharma | LIFE - Cost Of Sales


aTyr Pharma reported $1.31M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Ardelyx USD 4.81M 6.04M Mar/2026
aTyr Pharma USD 1.31M 2.04M Mar/2026
Biogen USD 797.5M 302M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Cipla INR 26.32B 2.79B Mar/2026
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.82M 1.71M Mar/2026
CSL USD 3.87B 2.08B Dec/2025
Curis USD 314K 9.96M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Grifols EUR 1.51B 184.45M Dec/2025
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
United Therapeutics USD 133.4M 341.3M Mar/2026
Xoma 116K 112.7K Jun/2024